590P A Double-Blind, Randomized, Parallel Group Study to Demonstrate the Equivalent Pharmacokinetic Properties of a Single Intravenous Dose HD201, a Trastuzumab Biosimilar Candidate, Versus EU Trastuzumab and US Trastuzumab

M. Demarchi,P. Coliat,J. Chung Shii Hii,P. Feyaerts, F. Ang, J. Litha,F. Deforce,A. Detappe, M. P. Derde, M. Kim,L. Park,P. Xavier

Annals of oncology（2020）

引用 0|浏览33

暂无评分

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要